Camarda Financial Advisors, LLC Novo Nordisk A S Transaction History

Camarda Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $1.45 Million - $1.74 Million	11,826 New	11,826 $1.69 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $173,453 - $208,369	1,976 New	1,976 $204,000
Q3 2022 Nov 07, 2022	BUY	$95.28 - $116.93 $301,847 - $370,434	3,168 New	3,168 $316,000
Q3 2019 Nov 14, 2019	SELL	$47.54 - $53.43 $28,286 - $31,790	-595 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$46.79 - $52.47 $3,088 - $3,463	66 Added 12.48%	595 $30,000
Q1 2019 Apr 25, 2019	BUY	$46.36 - $52.63 $24,524 - $27,841	529 New	529 $28,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Camarda Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Camarda Financial Advisors, LLC with notifications on news.